Skip to main content

Table 2 Stratified analyses of the pooled HRs of overall survival by tumor type, sample size, and survival analysis method

From: The prognostic value of long noncoding RNA SNHG16 on clinical outcomes in human cancers: a systematic review and meta-analysis

Subgroup analysis

No. of studies

No. of patients

Pooled HR (95% CI)

Heterogeneity

Fixed model

p-value

I2 (%)

p-value

Survival analysis method

 Univariate

2

149

1.88 (1.20, 2.96)

0.006

0.0

0.472

 Multivariate

4

280

1.86 (1.51, 2.30)

< 0.001

39.9

0.173

Tumor type

 Gynecologic tumor

2

141

1.89 (1.24, 2.89)

0.003

0.0

0.531

 Others

4

288

1.86 (1.50, 2.31)

< 0.001

41.3

0.164

Sample size

 < 60

3

132

1.72 (1.37, 2.16)

< 0.001

0.0

0.475

 ≥ 60

3

297

2.28 (1.60, 3.24)

< 0.001

11.4

0.324

Cut-off value

 Mean

2

149

1.88 (1.20, 2.96)

0.006

0.0

0.472

 Median

4

280

1.86 (1.51, 2.30)

< 0.001

39.9

0.173

  1. CI confidence interval, HR hazard ratio